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There is a growing body of evidence for the importance of the nuclear matrix in various nuclear events including gene
expression and DNA replication. Epstein–Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) is a nuclear matrix-
associated protein that has been suggested to play an important role in EBV-induced transformation. To define the biological
significance of the association of EBNA-LP with the nuclear matrix, we mapped the domain of EBNA-LP responsible for
nuclear matrix association and investigated the functions of the EBNA-LP mutant mutagenized by substitution of alanines for
the cluster of arginine residues in the mapped region. The results of the present study were as follows. (i) Transiently
expressed EBNA-LP in COS-7 or BOSC23 cells was associated with the nuclear matrix, similarly to that in EBV-infected B
cells. (ii) Mutational analysis of EBNA-LP revealed that a 10-amino acid segment of EBNA-LP is critical for nuclear matrix
association of the protein. Interestingly, the identified region overlapped with the region CR2 of EBNA-LP conserved among
a subset of primate gammaherpesviruses. The identified segment is referred to as EBNA-LP NMTS (nuclear matrix targeting
signal). (iii) The EBNA-LP mutant with the arginine to alanine substitutions in NMTS was no longer localized not only to the
nuclear matrix but also to the nucleus. (iv) The EBNA-LP mutant lacked its ability to coactivate EBNA-2-dependent
transactivation. These results indicated that EBNA-LP needs to be localized in the nucleus and/or associated with the nuclear
matrix through CR2 to elicit its function such as the coactivation of the EBNA-2-dependent transcriptional activation. © 2001
Academic PressINTRODUCTION
Epstein–Barr virus (EBV) is frequently associated with
a variety of neoplastic diseases including endemic Bur-
kitt’s lymphoma, nasopharyngeal carcinoma, Hodgkin’s
disease, several lymphomas, and gastric carcinoma
(Kieff, 1996; Rickinson and Kieff, 1996). In vitro, EBV can
efficiently immortalize human B cells (Kieff, 1996; Rickin-
son and Kieff, 1996). The resultant cell line, lymphoblas-
toid cell line (LCL), carries EBV genome in an episomal
form (Kieff, 1996; Rickinson and Kieff, 1996) and consti-
tutively expresses several viral proteins including six
EBV nuclear antigen (EBNA) proteins [EBNA-1, -2, -3A,
-3B, -3C, and leader protein (LP)] and three latent mem-
brane proteins (LMP) (LMP-1, -2A, and -2B; Kieff, 1996;
Rickinson and Kieff, 1996). Extensive studies have been
performed to determine the mechanisms of this immor-
talization process, and LMP-1, EBNA-2, EBNA-3A, and
EBNA-3C have been shown to be essential for the es-
1 To whom reprint requests should be addressed at Department of
umor Virology, Division of Virology and Immunology, Medical Re-
earch Institute, Tokyo Medical and Dental University, Yushima,
unkyo-ku, Tokyo, 113-8510, Japan. Fax: 81-3-5803-0241. E-mail:
awaguchi.creg@mri.tmd.ac.jp.c2 Deceased.
401tablishment of LCLs (Cohen et al., 1989; Hammerschmidt
and Sugden, 1989; Kaye et al., 1993; Tomkinson et al.,
1993).
Epstein–Barr virus nuclear antigen leader protein
(EBNA-LP), the subject of this report, is the first viral gene
product to be expressed together with EBNA-2 after EBV
infection of B cells (Alfieri et al., 1991). A genetic analysis
with recombinant viruses showed that EBNA-LP is not
essential for EBV-induced B-cell immortalization (Ham-
merschmidt and Sugden, 1989; Mannick et al., 1991).
However, the efficiency of B-cell immortalization by the
recombinant EBV lacking the C-terminal Y1Y2 domain of
EBNA-LP is severely reduced and LCLs established by
the recombinant virus require fibroblast-feeder cells for
proliferation (Mannick et al., 1991). These results support
the hypothesis that EBNA-LP is a critical regulator of
EBV-induced B-cell transformation. Although the mecha-
nisms by which EBNA-LP acts in EBV-induced B-cell
immortalization remain to be elucidated, several lines of
evidence listed below suggest roles of EBNA-LP in the
immortalization process. First, EBNA-LP has been dem-
onstrated to activate cellular and viral gene expression in
cooperation with EBNA-2. EBNA-LP and EBNA-2 coop-
eratively stimulate expression of cyclin D2 in resting B
cells and progression of these cells from G0 to G1 (Sin-lair et al., 1994). These proteins also cooperate in up-
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402 YOKOYAMA ET AL.regulating viral gene expression of LMP1 in B cells
(Harada and Kieff, 1997; Nitsche et al., 1997). Second,
EBNA-LP has been shown to interact with various cellu-
lar proteins. EBNA-LP was shown to bind to p53 and pRb
in in vitro binding assays (Szekely et al., 1993) and to be
colocalized with an antigenically distinct form of pRb in
nuclear domains named ND10 (Jiang et al., 1991, Szekely
et al., 1996). EBNA-LP and the 70-kDa family of heat-
shock proteins (hsp70s) are associated in vivo, colocal-
ized in ND10, and translocated to the nucleolus under
cellular stress conditions such as heat shock and high-
cell density (Mannick et al., 1995; Kitay and Rowe, 1996;
Szekely et al., 1995). Recently, we showed that EBNA-LP
is also localized in the cytoplasm and interacts with a
cellular cytoplasmic protein, HAX-1, that was suggested
to be involved in B-cell signal transduction and apoptosis
(Kawaguchi et al., 2000). These results suggested that
BNA-LP modulates the function of the interactive cellu-
ar proteins and EBNA-2-mediated activation of cellular
nd viral gene expression during EBV-induced immortal-
zation.
EBNA-LP associates with the nuclear matrix like other
BNAs such as EBNA-2, -3A, and -3C do (Petti et al.,
990). The nuclear matrix (also known as nuclear scaf-
old and nuclear skeleton) is a filamentous ribonucleo-
rotein complex composed of lamine polymers, core
ilaments, and associated proteins (Berenzy and Coffey,
975; Fey et al., 1984). A number of studies indicated that
he organization of this structure is linked to various
uclear events including transcription, splicing, and DNA
eplication (Mortillaro et al., 1996; Jackson and Cook,
995). For instance, the cellular transcription factor,
ML1 (PEBP2aB/Cbfa2) (Miyoshi et al., 1991; Bae et al.,
1993), controls transcription of its target genes as well as
polyomavirus DNA replication through association with
the nuclear matrix (Zeng et al., 1998; Kanno et al., 1998;
Chen et al., 1998). These results suggested the impor-
tance of the nuclear matrix in regulation of nuclear
events.
To demonstrate the significance of the interaction of
EBNA-LP with the nuclear matrix, we mapped and mu-
tagenized the nuclear matrix targeting signal (NMTS) of
EBNA-LP. Here, we report that amino acid substitutions
in the NMTS of EBNA-LP abolished not only its nuclear
matrix association but also nuclear localization of the
protein. We also showed that mutation of EBNA-LP ab-
rogated its cooperative transcriptional activation with
EBNA-2.
RESULTS
Transiently expressed EBNA-LP in COS-7 or BOSC23
cells is associated with nuclear matrix
Petti et al. (1990) previously reported that EBNA-LP is
associated with nuclear matrix in B cells latently infected
with EBV). One of the objectives of this report was to
identify the domain responsible for the association ofEBNA-LP with nuclear matrix. For this purpose, we used
COS-7 or BOSC23 cells and carried out transient trans-
fection assay in the cells using expression vectors for
various EBNA-LP mutants. First of all, we performed two
sets of experiments to confirm that transiently expressed
EBNA-LP is in fact localized at nuclear matrix in these
cells. The results were as follows.
(i) In the first series of experiments, FLAG epitope-
tagged EBNA-LP was transiently expressed in COS-7
cells and its association with nuclear matrix was inves-
tigated by in situ nuclear matrix isolation and subsequent
indirect immunofluorescence assay using a monoclonal
antibody to FLAG epitope (M2). As shown in Fig. 1A,
EBNA-LP was clearly detected after nuclease digestion
(Fig. 1A–c), while DNA staining by DAPI was barely
detectable (Fig. 1A–d), indicating that EBNA-LP is re-
tained at nuclear matrix in situ.
(ii) In the second series of experiments, BOSC23 cells
were transfected with indicated expression plasmids,
fractionated as described under Materials and Methods,
subjected to electrophoresis in denaturing gels, trans-
ferred to nitrocellulose sheets, and reacted to the anti-
FLAG antibody (M2). As shown in Fig. 1B, the major
portion of EBNA-LP transiently expressed in BOSC23
cells was detected in the nuclear matrix fraction (Fig. 1B,
lane 10) and the small protein was also found in other
subnuclear fractions (Fig. 1B, lanes 7 to 9). These results
were consistent with those of a previous study using
EBV-infected B cells (Petti et al., 1990). Figure 1C shows
that AML1b, which is known to be sequestered into the
nuclear matrix (Zeng et al., 1997), was detected in the
nuclear matrix fraction, while the alternatively spliced
form of AML1b, AML1a, that lacks ability to localize in the
nuclear matrix (Miyoshi et al., 1995; Chen et al., 1998),
was not detectable in this fraction. This confirmed that
cells were appropriately fractionated in these experi-
ments. These results indicated that transiently ex-
pressed EBNA-LP in COS-7 or BOSC23 cells was asso-
ciated with the nuclear matrix.
W2 repeat domain of EBNA-LP is responsible for
association of the protein with the nuclear matrix
To map the domain of EBNA-LP that is involved in
association of the protein with the nuclear matrix, we
constructed a series of deletion mutants of EBNA-LP
(Fig. 2A) and tested whether these mutants transiently
expressed in BOSC23 cells were localized in the nuclear
matrix. Preliminary experiments indicated that molecules
with only one W repeat domain were difficult to express
in BOSC23 cells, presumably due to their instability (data
not shown). We, therefore, constructed plasmids ex-
pressing FLAG epitope-tagged EBNA-LP mutants fused
to the GAL4 DNA binding domain to increase the stability
of the proteins. Whole-cell extract and nuclear matrix
fraction were prepared as described under Materials
and Methods, separated in a denaturing gel, and sub-
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403IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPjected to immunoblotting with an antibody to the GAL4
DNA binding domain (RK5C1). As shown in Fig. 2A, Y1Y2-
deleted EBNA-LP associated with the nuclear matrix as
efficiently as wild-type EBNA-LP (Fig. 2B, lanes 3 to 6),
indicating that the domain of the EBNA-LP protein respon-
sible for the nuclear matrix association is the W repeat
domain. These results were confirmed by in situ nuclear
matrix isolation and subsequent immunofluorescence as-
says using an antibody to FLAG epitope (M2) (Fig. 2C).
FIG. 1. Transiently expressed EBNA-LP in COS-7 or BOSC23 cells wa
transfected with pcDNA4/HisMax-EBNA-LP(F) on immunofluorescence
ransfected cells were analyzed for the presence of EBNA-LP by immu
onjugated to fluorescein isothiocyanate (FITC) (a, c). DNA content was
f electrophoretically separated subcellular fractions of BOSC23 cells tr
mpty expression vector (vector) or pEBVHis-EBNA-LP(F) (EBNA-LP(F))
qually; one was solubilized as whole-cell extract, and the other was fr
hen subjected to electrophoresis in a denaturing gel, transferred on
ntibody (M2). Molecular weights (kDa) are shown on the right. The s
oluble, histone H1, and chromatin fractions, respectively. The nuclear m
uffer. (C) Photographic image of an immunoblot of electrophoretically
xpression vector (v), pLNSX-FLAG-AML1a ((F)AML1a), or pLNSX-FLAG
B) and subjected to immunoblotting with the anti-FLAG antibody (M2)Three further EBNA-LP mutants were generated todetermine whether the copy number of W repeats of
EBNA-LP influences the association with the nuclear
matrix (Fig. 2A). The results shown in Fig. 2B indicated
that the ratio of EBNA-LP mutants detected in the nuclear
matrix fraction to that in the whole-cell extract was re-
duced as the copy number of W repeat decreased. These
results suggested that association of EBNA-LP with the
nuclear matrix depends on the number of W repeats of
the protein and it is likely that the affinity to the nuclear
ciated with the nuclear matrix. (A) Photographic images of COS-7 cells
Whole cells (WC) and in situ nuclear matrix (NM) preparations of the
escence assay with the anti-FLAG antibody (M2), and anti-mouse IgG
ized by DAPI staining (b, d). (B) Photographic image of an immunoblot
ted with the indicated vectors. BOSC23 cells were transfected with the
rvested 48 h after transfection. The cells were divided into two pools
ted as described under Materials and Methods. The cell lysates were
itrocellulose sheet, and subjected to immunoblotting with anti-FLAG
fractions in CSK, extraction, and digestion buffers are referred to as
action was the residual insoluble fraction after treatment with digestion
ted subcellular fractions of BOSC23 cells transfected with the empty
b ((F)AML1b). The transfected cells were fractionated as described in
ular weights (kDa) are shown on the right.s asso
assay.
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405IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPincreases. The experiments using in situ nuclear matrix
isolation and subsequent immunofluorescence assays
with GAL4-EBNA-LP mutants with different copy num-
bers of W repeats revealed that approximately 30% of cells
expressing EBNA-LP derivatives containing more than two
W repeats clearly showed their nucleolar localization (Fig.
2C, a–c and i–k) as reported previously (Szekely et al.,
1995), while EBNA-LP with only a single W repeat was no
longer localized in the nucleolus (Fig. 2C, d and l).
The W repeat of EBNA-LP consists of W1 and W2
domains. Next, we attempted to determine which domain
of the W repeat is responsible for the nuclear matrix
localization of EBNA-LP. We constructed various HA-
tagged EBNA-LP mutants fused to the GAL4 DNA bind-
ing domain in expression plasmids (Fig. 2D) examined
whether their products were detected in the nuclear
matrix fraction of COS-7 cells. Although GAL4-EBNA-
LPR1d1 was not detectable in the nuclear matrix fraction
as shown in Fig. 2B, it was detected when 10-fold con-
centrated cell lysate was subjected to immunoblotting
(data not shown). Further, we used an antibody to the HA
epitope (3F10) to detect the HA-tagged GAL4-EBNA-LP
fusion proteins because it can detect the fusion protein
more sensitively than the antibody to the GAL4 DNA
binding domain (RK5C1) (Fig. 2E, lanes 1 and 2). The
results (Fig. 2F) showed that all GAL4 and GAL4-
EBNA-LP proteins were expressed in the nucleus, while
only the GAL4-W2 fusion protein was detectable in the
nuclear matrix. These results were confirmed by cell
fractionation analysis as shown in Fig. 2E. Although the
expression level of GAL4-Y1Y2 is lower than that of other
GAL4 fusion proteins, it could not be detected in the
nuclear matrix fraction even with the much longer expo-
sure. These results indicated that the W2 domain of
EBNA-LP is involved in its nuclear matrix localization.
CR2 region of the W2 domain of EBNA-LP is
essential for its nuclear matrix localization
To further map the site of EBNA-LP interacting with the
nuclear matrix, we constructed a series of 39 sequential
FIG. 2. Mapping of the domain of EBNA-LP responsible for nuclear
of EBNA-LP fused to the GAL4 DNA binding domain (GAL4 DBD) tagge
localization of the mutants are also shown. (B) Photographic image of an
cells transfected with a series of expression vectors for EBNA-LP mutan
matrix fractions (N) were prepared as described under Materials and M
nitrocellulose sheet, and subjected to immunoblotting with anti-GAL4 D
the right. (C) Photographic images of COS-7 cells transfected with the
of W repeats on immunofluorescence assay. At 48 h after transfection
described under Materials and Methods were fixed, subjected to im
conjugated to FITC. DNA was detected by DAPI staining (e to h). (D) Sc
or Y1Y2 domain of EBNA-LP fused to the GAL4 DNA binding domain (G
of nuclear matrix association of the mutants are also shown. (E) Photo
fractions of BOSC23 cells transfected with the expression vectors for
fractions (N) of the transfected cells were analyzed as described in (B)
right. (F) Photographic images of BOSC23 cells were transfected with
rescence assay. Localizations of EBNA-LP mutants in whole cells (WC
using the anti-HA antibody (3F10), and anti-rat IgG conjugated to rhodamine.and internal deletion mutants of the W2 domain tagged
with HA at the C-terminal ends and fused to the GAL4
DNA binding domain in expression plasmids as shown
in Fig. 3B and tested them for their association with the
nuclear matrix by cell fractionation and immunoblotting
probed with the antibody to the HA epitope (3F10). As
shown in Fig. 3C, the site in the W2 domain of EBNA-LP
that interacts with the nuclear matrix mapped the amino
acids EPRRVRRRVL between codon 21 to 30 (relative to
the first amino acid residue of the W2 domain; Fig. 3A).
Interestingly, the mapped region was completely over-
lapped with the conserved region, named CR2 (Peng et
al., 2000), among a subset of primate gammaherpesvi-
ruses (Fig. 3A). Next, we mutagenized the GAL4-W2 con-
struct by replacing clustered arginine residues in the
region between codons 21 to 30 to alanines as described
under Materials and Methods (Figs. 3A and 3D). The
experiments with the mutant (GAL4-W2RA) showed that
the amino acid substitutions resulted in abolishment of
nuclear matrix association of the protein (Figs. 3E and
3F), although the mutant protein was expressed in the
nucleus (Fig. 3F, d).
From these results, we concluded that the 10-amino
acid segment from codons 21 to 30 in the W2 domain of
EBNA-LP is the major determinant of its interaction with
the nuclear matrix. We referred to this segment as the
nuclear matrix targeting signal (NMTS) of EBNA-LP.
NMTS of EBNA-LP is critical for its nuclear
localization as well as its nuclear matrix association
Nitsche et al. (1997) previously reported that more than
two copies of the W repeat are required for EBNA-LP to
express one of its biological phenotypes, the up-regula-
tion of LMP1 expression in combination with EBNA-2. To
investigate the importance of nuclear matrix localization
for the function of EBNA-LP in more detail, we mu-
tagenized the EBNA-LP cDNA containing four repeats of
W domains in the expression vector by introducing the
same alanine substitutions for the clustered arginine in
NMTS of each W repeat domain (Fig. 4A). BOSC23 cells
association. (A) Schematic representation of various deletion mutants
FLAG epitope. The levels of nuclear matrix association and nucleolar
noblot of electrophoretically separated subcellular fractions of BOSC23
wn in (A). At 48 h after transfection, whole-cell extracts (W) and nuclear
, separated by electrophoresis in a denaturing gel, transferred onto a
ding domain antibody (RK5C1). Molecular weights (kDa) are shown on
ed expression vectors for GAL4-EBNA-LP containing various numbers
e cells (WC) (a to d) or nuclear matrix (NM) (i to l) isolated in situ as
luorescence with the anti-FLAG antibody (M2), and anti-mouse IgG
ic representation of each EBNA-LP mutant expressing W1W2, W1, W2,
D) tagged with an epitope of influenza hemagglutinin (HA). The levels
image of an immunoblot of electrophoretically separated subcellular
LP mutants shown in (D). Whole-cell extracts (W) and nuclear matrix
he anti-HA antibody (3F10). Molecular weights (kDa) are shown on the
pression vectors for EBNA-LP mutants shown in (D) on immunofluo-
d) and nuclear matrix (NM) (e to h) were analyzed as described in (C)matrix
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407IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPwere transfected with the indicated expression plas-
mids, solubilized, and subjected to immunoblotting with
the monoclonal antibody to the FLAG epitope (M2) or
EBNA-LP (JF186). As shown in Fig. 4B, EBNA-LP with the
mutation was expressed in BOSC23 cells. The EBNA-LP
mutant (EBNA-LPRA(F)) migrated more slowly than wild-
type EBNA-LP in denaturing gels (Fig. 4B) possibly be-
cause the amino acid substitutions resulted in a change
in electronic charge of the mutant protein. Surprisingly,
when localization of transiently expressed EBNA-
LPRA(F) was examined in COS-7 cells by immunofluo-
rescence assay with anti-FLAG antibody, the mutant pro-
tein was detected only in the cytoplasm of the cells (Fig.
4C). To confirm these results, BOSC23 cells transiently
transfected with wild-type EBNA-LP or the mutant
EBNA-LP expression vector were fractionated as de-
scribed under Materials and Methods and each fraction
was subjected to electrophoresis in denaturing gels and
immunoblotting with anti-FLAG antibody. The results
(Fig. 4D) showed that wild-type EBNA-LP was detectable
mainly in the nuclear fractions (Fig. 4D, lanes 4 to 7) as
well as in the cytoplasmic fraction (Fig. 4D, lane 3), while
the mutant EBNA-LP was detected only in the cytoplasm
(Fig. 4D, lane 9). These results indicated that NMTS of
EBNA-LP is responsible not only for its nuclear matrix
association but also for its nuclear localization.
EBNA-LPRA fused to GAL4 DNA binding domain is
retained in cytoplasm of COS-7 cells
To further investigate the mechanism by which the
EBNA-LP mutant (EBNA-LPRA) is localized in the cyto-
plasm, we constructed EBNA-LPRA mutant fused to
GAL4 DNA binding domain in an expression vector (Fig.
5A). In BOSC23 cells transfected with the expression
plasmids [pM-EBNA-LP(F) and pM-EBNA-LPRA(F)], the
expected proteins were expressed (Fig. 5B). Earlier stud-
ies indicated that the GAL4 DNA binding domain pos-
sesses a nuclear localization signal (NLS) within the
domain from codons 1 to 74 that is sufficient to translo-
cate heterologous cytoplasmic proteins into the nucleus
FIG. 3. CR2 of EBNA-LP is the region responsible for nuclear matrix a
regions defined by Peng et al. (2000) are indicated as broken lines wi
the segment mapped by truncation of the W2 sequence are also ind
mutants of W2 domain fused to the GAL4 DNA binding domain tagged
is also shown. (C) Photographic images of immunoblots of electrophor
BOSC23 cells transfected with the indicated expression vectors for EB
under Materials and Methods, separated by electrophoresis in denatu
blotting with the anti-HA antibody (3F10). Molecular weights (kDa) are
mutants of EBNA-LP W2 domain fused to the GAL4 DNA binding doma
the amino acids between codons 21 to 30 (relative to the first amino a
region. (E) Photographic image of an immunoblot of electrophoretically
(NM) (lanes 5 to 8) of BOSC23 cells transfected with the indicated exp
and nuclear matrix fractions (NM) of the transfected cells were analyz
(kDa) are shown on the right. (F) Photographic images of BOSC23 cel
in (D) on immunofluorescence assay. Localizations of EBNA-LP mutant
as described in Fig. 2F using the anti-HA antibody (3F10), and anti-rat IgG co(Silver et al., 1984). COS-7 cells were transfected with the
indicated plasmids, fixed 2 days after transfection, re-
acted with the anti-GAL4 antibody (RK5C1), and exam-
ined with a Nikon fluorescence microscope. As shown in
Fig. 5C, GAL4 by itself and wild-type EBNA-LP fused to
GAL4 DNA binding domain were detected as nuclear
staining. In contrast, EBNA-LPRA was still localized in
the cytoplasm of the cells even when the mutant was
expressed as a fusion protein with the GAL4 DNA bind-
ing domain (Fig. 5C). These results raised two possibil-
ities that (i) EBNA-LP possesses nuclear export signal to
be excluded from the nucleus, or (ii) the protein has a
domain that is involved in its retention in the cytoplasm.
EBNA-LPRA lacks the ability to stimulate EBNA-2-
mediated transcriptional activation
To examine the biological significance of nuclear and
nuclear matrix localization of EBNA-LP, we performed
two series of experiments.
Harada and Kieff (1997) reported that EBNA-LP is a
coactivator for EBNA-2-dependent transcriptional activa-
tion. In the first series of experiments, the expression
vector for EBNA-2 fused to the GAL4 DNA binding do-
main was constructed and tested for coactivation with
EBNA-LP or EBNA-LPRA in COS-7 or BOSC23 cells co-
transfected with a reporter construct (pFR-luc) containing
five tandem repeats of the 17bp GAL4 binding element
upstream of a basic promoter element (TATA box). At 48 h
after transfection, the cells were harvested and sub-
jected to luciferase assay as described under Materials
and Methods. As shown in Figs. 6A and 6B, wild-type
EBNA-LP significantly stimulated EBNA-2-mediated tran-
scriptional activation by approximately 20-fold, while
EBNA-LPRA did not.
Nitsche et al. (1997) also reported that transiently ex-
pressed EBNA-LP along with EBNA-2 induces endoge-
nous LMP-1 expression in EBV-positive cell lines. In the
second series of experiments, wild-type EBNA-LP or
EBNA-LPRA mutant along with EBNA-2 was introduced
into Akata cells. We examined the LMP-1 expression by
tion. (A) The amino acid sequence of W2 exon of EBNA-LP. Conserved
designation given above. Arginine to alanine substitutions (W2RA) in
(B) Schematic representation of 39 sequential, and internal deletion
he HA epitope. The level of nuclear matrix association of the mutants
separated whole-cell extract (WC) and nuclear matrix fraction (NM) of
mutants are shown in (B). Cell extracts were prepared as described
els, transferred onto nitrocellulose sheets, and subjected to immuno-
on the right of each panel. (D) Schematic representations of various
ed with the HA epitope, including the internal deletion mutant lacking
idue of W2 domain), and arginine–alanine substitution mutant in this
ated whole-cell extract (WC) (lanes 1 to 4) and nuclear matrix fraction
vectors for EBNA-LP mutants shown in (D). Whole-cell extracts (WC)
escribed in (C) using the anti-HA antibody (3F10). Molecular weights
transfected with the expression vectors for EBNA-LP mutants shown
ole cells (WC) (a to d) and nuclear matrix (NM) (e to h) were analyzedssocia
th their
icated.
with t
etically
NA-LP
ring g
shown
in tagg
cid res
separ
ression
ed as d
ls were
s in whnjugated to rhodamine.
a
w
t
(
m
a
a
m
a
l
E
l
anel.
408 YOKOYAMA ET AL.immunoblotting with anti-LMP-1 monoclonal antibody (S-
12). As shown in Fig 6C, EBNA-LPRA failed to induce
LMP-1 expression, while EBNA-LP efficiently induces the
expression of LMP-1 as reported previously (Nitsche et
l., 1997). The expressions of EBNA-LPs and EBNA-2
ere also examined with anti-EBNA-LP monoclonal an-
ibody (JF186) and anti-EBNA-2 monoclonal antibody
PE2), respectively.
These results indicated that nuclear and/or nuclear
atrix localization of EBNA-LP are essential for cooper-
FIG. 4. CR2 is responsible for not only nuclear matrix localization b
tagged wild-type EBNA-LP and EBNA-LPRA mutant with arginine to ala
Photographic images of immunoblots of electrophoretically separat
pcDNA4/HisMax-EBNA-LP(F) (EBNA-LP(F)), or pcDNA4/HisMax-EBNA-
(M2) (left panel) or the mouse monoclonal antibody to EBNA-LP (JF186
(C) Photographic images of COS-7 cells transfected with pcDNA4/H
LPRA(F)) on immunofluorescence assay. The EBNA-LP proteins were v
IgG antibody (left panels). DNA was stained with DAPI (right panels)
subcellular fractions of BOSC23 cells transfected with pcDNA4/HisMa
EBNA-LPRA(F) (EBNA-LPRA(F)). The transfected cells were fractionated
denaturing gels, transferred onto nitrocellulose sheets, and reacted
fraction was obtained as described in Fig. 1B. The nucleoplasm was th
CSK buffer. Molecular weights (kDa) are shown on the right of each ptive transcriptional activation with EBNA-2. fDISCUSSION
The salient features of this study can be summarized
s follows.
(i) We defined a 10-amino acid segment as NMTS that
ediates association of EBNA-LP with the nuclear matrix
nd also showed that the NMTS is essential for nuclear
ocalization of EBNA-LP. We referred to this segment as
BNA-LP NMTS/NLS. Three lines of evidence listed be-
ow supported our conclusion. First, EBNA-LP possesses
nuclear localization. (A) Schematic representation of FLAG epitope-
ubstitutions in nuclear matrix targeting signal (NMTS) of EBNA-LP. (B)
tes of BOSC23 cells transfected with pcDNA4/HisMax vector (v),
) (EBNA-LPRA(F)). The blots were probed with the anti-FLAG antibody
panel). Molecular weights (kDa) are shown on the right of each panel.
EBNA-LP(F) (EBNA-LP(F)) or pcDNA4/HisMax-EBNA-LPRA(F) (EBNA-
ed with the anti-FLAG antibody (M2) and FITC-conjugated anti-mouse
hotographic images of immunoblots of electrophoretically separated
r (v), pcDNA4/HisMax-EBNA-LP(F) (EBNA-LP(F)), or pcDNA4/HisMax-
cribed under Materials and Methods, separated by electrophoresis in
ti-FLAG antibody. Each subnuclear fraction except the nucleoplasm
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409IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPamong gammaherpesvirus EBNA-LP homologues (Peng
et al., 2000), and these regions are suggested to be
important functional domains of the protein. As pre-
dicted, our mutational analyses of EBNA-LP revealed
that one of the conserved regions, CR2, plays essential
roles in both nuclear matrix association and nuclear
localization of EBNA-LP. Second, EBNA-LP NMTS/NLS
shares similar features with typical NLSs. NLSs fall into
two categories: a single-type signal consisting of a
stretch of basic amino acids such as NLS of simian virus
40 T antigen (Kalderon et al., 1984), and a bipartite signal
consisting of two basic amino acid stretches separated
by a 10-amino acid spacer such as that of nucleoplasmin
(Dingwall et al., 1988; Robbins et al., 1991). As shown in
Fig. 7, EBNA-LP NMTS/NLS is composed of a cluster of
basic amino acid and shows significant similarity to the
single-type NLS of simian virus 40 T antigen. Further-
more, the EBNA-LP NMTS/NLS together with another
conserved region, CR1c, showed similarities to a nucleo-
plasmin-like bipartite NLS (Fig. 7). CR1c consists of a
cluster of basic amino acids positioned approximately
10-amino acids upstream of the EBNA-LP NMTS/NLS.
Third, Zou et al. (2000) recently reported that a cluster of
basic amino acids residues of E2 protein of human
papillomavirus type 11 (HPV-11) is required for both nu-
clear localization and nuclear matrix association. As
shown in Fig. 7, EBNA-LP NMTS/NLS showed consistent
homology with the cluster of basic amino acids in HPV-11
E2 protein. Taken together, these observations support
FIG. 5. EBNA-LP RA mutant fused to the GAL4 DNA binding domain is
r EBNA-LP RA mutant fused to GAL4 DNA binding protein tagge
lectrophoretically separated lysates of BOSC23 cells transfected with p
ntibody (M2). Arrows indicate each band of GAL4-EBNA-LP or GAL4
M-EBNA-LP(F), or pM-EBNA-LPRA(F), fixed and reacted with anti-GAour conclusion that EBNA-LP NMTS/NLS identified inthis study is critical for both nuclear localization and
nuclear matrix association.
(ii) EBNA-LPRA mutant fused to the GAL4 DNA binding
domain is retained in the cytoplasm although the GAL4
DNA binding domain is known to have the ability to
confer nuclear localization on heterologous cytoplasmic
proteins (Silver et al., 1984). These results suggested that
EBNA-LP contains a functional domain responsible for
cytoplasmic retention as well as NMTS/NLS for import
into the nucleus. This may account for our recent obser-
vation that EBNA-LP containing a single W repeat tran-
siently expressed in COS-7 cells was localized predom-
inantly in the cytoplasm, while EBNA-LPs with more than
two W repeats were mainly localized in the nucleus
(Kawaguchi et al., 2000). It appears that EBNA-LPs with
more than two W repeats have sufficient ability to be
transported into the nucleus, while the ability of EBNA-LP
with only one W repeat to retain in the cytoplasm is
stronger than the ability to be translocated to the nu-
cleus. Taken together, these results suggest that more
than two NMTS/NLS are required for efficient nuclear
localization of the protein.
(iii) EBNA-LP with a single W repeat shows biological
activities different from those of EBNA-LPs with more
than two W repeats. First, Nitsche et al., (1997) reported
that the stimulation of EBNA-2-dependent transactivation
requires more than two copies of the W repeat of EBNA-
LP. Second, we previously reported that two copies of the
W repeat of EBNA-LP are necessary for its nuclear lo-
d in the cytoplasm. (A) Schematic representation of wild-type EBNA-LP
the FLAG epitope. (B) Photographic image of an immunoblot of
A-LP(F) or pM-EBNA-LPRA(F). The blot was probed with the anti-FLAG
-LPRA. (C) Photographic images of COS-7 cells transfected with pM,
binding domain (RK5C1), and anti-mouse IgG conjugated to FITC.retaine
d with
M-EBN
-EBNAcalization as described above (Kawaguchi et al., 2000).
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410 YOKOYAMA ET AL.Third, we showed here that the nucleolar localization of
EBNA-LP requires more than two copies of the W repeat.
Although the biological significance of nucleolar local-
ization of EBNA-LP is unknown at present, there might be
FIG. 6. The EBNA-LPRA mutant failed to stimulate EBNA-2-dependen
P(F) (EBNA-LPR4), or pcDNA4/HisMax-EBNA-LPRA(F) (EBNA-LPR4RA)
lates with 1 mg of pM-EBNA-2, 0.16 mg of pFR-luc, and 0.016 mg of p
ctivity as described under Materials and Methods. Fold activation r
epresent averages of two independent experiments, each of which w
ndependent experiments, each of which was performed in duplicate
pcDNA4/HisMax-EBNA-LP(F) (EBNA-LP), or pcDNA4/HisMax-EBNA-L
ME-EBNA-2 (EBNA-2) by electroporation. At 48 h after transfection, c
onoclonal antibody (JF186), anti-EBNA-2 mouse monoclonal antibody
FIG. 7. Comparison of amino acid sequence of EBNA-LP CR2 with
typical nuclear localization signals, and a signal for both nuclear localiza-
tion, and nuclear matrix localization identified in human papillomavirus
type 11 (HPV-11) E2 protein. The numbers in front of the amino acid sequences
refer to the positions relative to the first amino acid of each protein.a possibility that the nucleolar localization of the protein
is linked to its biological activity.
(iv) There is accumulating evidence suggesting the
importance of the nuclear matrix in regulation of gene
expression. It has been reported that the nuclear matrix
associated protein EBNA-LP is a coactivator of EBNA-2-
mediated transcriptional activation (Harada and Kieff,
1997). Although it is unknown whether nuclear matrix
association of EBNA-LP is important for its function as a
coactivator, we show that mutations in NMTS/NLS of
EBNA-LP abrogated its cooperative transcriptional acti-
vation with EBNA-2. As mutant EBNA-LP that was unable
to associate with the nuclear matrix was not localized in
the nucleus, we could not directly address whether nu-
clear matrix association of EBNA-LP is critical for its
regulatory function. However, this is probably the case,
based on the following observations. First, it has been
reported that NMTS of the transcriptional regulator
AML1/CBFa can act as a transcriptional activation do-
main (Zeng et al., 1998). Second, the nuclear matrix has
been suggested to be scaffold for various nuclear events
including gene expression (Jackson and Cook, 1995) and
it would therefore be important to target EBNA-LP to the
right place.
activation. 0.33 mg of pcDNA4/HisMax vector, pcDNA4/HisMax-EBNA-
transfected into BOSC23 cells (A) or COS-7 cells (B) cultured in 24-well
t 48 h after transfection, cells were lysed and assayed for luciferase
to that with the pcDNA4/HisMax vector is shown. The results in (A)
formed in quadruplicate. The results in (B) represent averages of two
kata cells were transfected with 5 mg of pcDNA4/HisMax vector (v),
(EBNA-LPRA) in combination with 20 mg of pME18S vector (V) or
re lysed and subjected to Western blotting with anti-EBNA-LP mouse
anti-LMP-1 mouse monoclonal antibody (S-12).t trans
was co
RL-tk. A
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411IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPEBNA-LP involved in both nuclear matrix association and
nuclear localization. The identified sequence of EBNA-LP
showed similarity to NMTS/NLS of HPV-11 E2, raising the
possibility that a new type of specific signal for both
nuclear matrix association and nuclear localization ex-
ists in a subset of proteins.
MATERIALS AND METHODS
Cells
BOSC23 cells are derived from 293T cells (Pear et al.,
1993). BOSC23 and COS-7 cells were grown in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS). Akata cells are derived
from a sporadic Burkitt’s lymphoma (Takada and Ono,
1989). Akata cells were grown in RPMI medium supple-
mented with 10% fetal calf serum (FCS).
Plasmids
pEBVHis-EBNA-LP(F) was generated by cloning the
EBNA-LP cDNA (a generous gift from Dr. Kieff) tagged
with the FLAG sequence at its C-terminal end into the
pEBVHis vector (Invitrogen). pME-EBNA-2 was con-
structed by cloning the EcoRI fragment of pSG-E2 (a
generous gift from Dr. Fujiwara) into the EcoRI site of
pME18S (a generous gift from Dr. Maruyama). pM-
EBNA-2 was generated by inserting the EcoRI fragment
of pSG-E2 into the EcoRI site of pM (Clontech) in frame
with the GAL4 DNA binding domain. pMn was identical
to pM except that a NotI site was introduced in front of
he XbaI site of pM. pM-EBNA-LP(F) was generated by
loning the BamHI-NotI fragment of pEBVHis-EBNA-
P(F) containing the entire coding region of EBNA-LP
agged with the FLAG epitope sequence into BamHI-NotI
sites of pMn in frame with the GAL4 DNA binding do-
main. Deletion mutants of pM-EBNA-LP(F) (Fig. 2A) were
constructed by cloning into pMn the DNA fragments
amplified by polymerase chain reaction (PCR) with ap-
propriate primer pairs. The resultant plasmids expressed
various FLAG-tagged EBNA-LP mutants fused to the
GAL4 DNA binding domain. Plasmids (Figs. 2D and 4B)
expressing various HA-tagged EBNA-LP domains fused
to the GAL4 DNA binding domain were constructed by
cloning DNA fragments amplified by PCR using appro-
priate primer pairs into pM. To generate pM-W2-RA(H)
(Fig. 3D) and pM-EBNA-LPRA(F) (Fig. 5A), the arginine
codons in the region mapped by deletion analysis were
replaced with alanine codons using the GeneEditor in
itro Site-Directed Mutagenesis System (Promega) with
he oligonucleotide 59-CCAGTCCTACCAGAGGGGGCCA-
GAACCCGCAGCAGTCGCGGCCGCGGTCCTCGTCCAG-
AAGAAGAGGAGGTGG-39 according to the manufactur-
r’s instructions. pcDNA4/HisMax-EBNA-LP(F) and
cDNA4/HisMax-EBNA-LPRA(F) were generated by
loning the EcoRI-XbaI fragments of pM-EBNA-LP(F)
nd pM-EBNA-LPRA(F), respectively, into the pcDNA4/HisMax C vector (Invitrogen). pLNSX-(F)AML1a and
pLNSX-(F)AML1b were constructed by cloning of the
StuI/HindIII fragment of the PCR product amplified from
the cDNA of AML1a or AML1b with appropriate primer
pairs, one of which contained the FLAG epitope se-
quence, into pLNSX (Miller et al., 1993).
Transfection
COS-7 or BOSC23 cells were seeded 1 day before
transfection and 60–80% confluent cells were transfected
with various expression plasmids by calcium phosphate
precipitation using the Profection mammalian transfec-
tion system (Promega). Twelve hours after transfection,
the cells were washed and placed in fresh DMEM
growth medium. At 48 h after transfection, the cells were
harvested and used for further experiments. Akata cells
growing in log phase were washed twice with RPMI
supplemented with 10% FCS. 107 cells were suspended
n 0.5 ml of RPMI 10% FCS medium and mixed with 25 mg
f DNA. Cells were electroporated at 0.327 kV and 960
mF and then suspended in 10 ml of RPMI 10% FCS
medium and cultured at 37°C in humidified 5% CO2. Cells
were harvested 48 h after transfection by pelleting down
and washed with phosphate buffered saline (PBS) and
lysed with SDS-PAGE sample buffer at the concentration
of 5 3 107 cells/ml.
Cellular fractionation
Nuclear and cytoplasmic fractions were obtained by
the method described previously (Kawaguchi et al.,
1997a). Briefly, BOSC23 cells transiently transfected with
various EBNA-LP expression plasmids were harvested,
washed with PBS, and resuspended in buffer A [10 mM
HEPES [pH 7.4], 1.5 mM MgCl2, 10 mM NaCl, 1 mM
AEBSF (4-(2-aminoethyl) benzene sulfonyl fluoride)
(Boeringer Mannheim)]. The cells were then lysed by
addition of Nonidet-P40 to 0.1% and the nuclei were
pelleted by centrifugation at top speed in a microcentri-
fuge. The supernatant (cytoplasmic fraction) was trans-
ferred to a new tube. The pellet was washed twice with
buffer A, resuspended with CSK buffer [10 mM PIPES [pH
6.8], 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 1 mM
EGTA, 0.5% Triton X-100, 2 mM VRC (vanadyl riboside
complex) (5 Prime–3 Prime), 1 mM AEBSF], and sub-
jected to nuclear matrix fractionation. Subnuclear frac-
tionation was performed as described elsewhere (Fey et
al., 1984; Spector et al., 1998) by sequential extraction
with CSK buffer and extraction buffer (10 mM PIPES [pH
6.8], 250 mM ammonium sulfate, 300 mM sucrose, 3 mM
MgCl2, 1 mM EGTA, 2 mM VRC, 1 mM AEBSF) each for
min at 4°C, and then incubated with digestion buffer
10 mM PIPES [pH 6.8], 300 mM sucrose, 50 mM NaCl, 3
M MgCl2, 1 mM EGTA, 0.5% Triton X-100, 2 mM VRC, 1
mM AEBSF, 300 units/ml of RNase-free DNaseI (Roche)]
for 50 min at 32°C. Nucleoplasm, histone H1, and chro-
matin fractions were soluble materials obtained after
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respectively. The residual insoluble fractions after extrac-
tion with digestion buffer were used as the nuclear
matrix fractions.
In situ nuclear matrix isolation and indirect
immunofluorescence
To isolate nuclear matrix in situ (Fey et al., 1984,
Spector et al., 1998), cells on coverslips were washed
with PBS and extracted in CSK buffer and extraction
buffer for 4 min at 4°C. DNA digestion was performed in
digestion buffer at 32°C for 50 min followed by treatment
with extraction buffer twice. The cells were then fixed in 4%
formaldehyde in PBS. Whole-cell samples were directly
fixed in 4% formaldehyde in PBS, followed by permeabili-
zation with 0.25% Triton X-100 in PBS.
For immunofluorescence assays, the fixed cells were
blocked for 1 h at 37°C in PBS containing 10% FCS,
reacted for 1.5 h at 37°C with appropriate primary anti-
body, rinsed three times with PBS, reacted for 1 h at 37°C
with appropriate secondary antibody, rinsed three times
with PBS, and mounted in PBS containing 90% glycerol.
Goat anti-mouse and anti-rabbit IgG conjugated to fluo-
rescein isothiocyanate (FITC) and goat anti-mouse and
anti-rat IgG conjugated to rhodamine (Santa Cruz Bio-
technology) were used as secondary antibodies. For
DAPI staining, the fixed cells were reacted in 2 mg/ml
DAPI in PBS for 3 min at room temperature, then washed
four times with PBS and mounted in PBS containing 90%
glycerol. The coverslips were examined with a Nikon
fluorescence microscope.
Immunoblotting
The electrophoretically separated proteins transferred
onto nitrocellulose sheets were reacted with appropriate
antibodies as described elsewhere (Kawaguchi et al.,
1997b). Briefly, the nitrocellulose sheets were blocked
with 5% skim milk in T-PBS (PBS containing 0.1% Tween
20) for 1 h or overnight, rinsed twice, washed once for 15
min and twice for 5 min, and reacted for 2 h with primary
antibodies. The blots were then washed as before, re-
acted for 1 h with peroxidase-conjugated goat anti-
mouse IgG (Santa Cruz Biotechnology), rinsed twice,
washed once for 15 min and four times for 5 min each
time in T-PBS, and developed using the ECL chemilumi-
nescence reagent (Amersham-Pharmacia).
Antibodies
Anti-FLAG mouse monoclonal antibody (M2; Sigma),
anti-HA rat monoclonal antibody (3F10; Boehringer
Mannheim), anti-GAL4 DNA binding domain mouse
monoclonal antibody (RK5C1; Santa Cruz Biotechnology),
anti-EBNA2 mouse monoclonal antibody (PE2; DAKO),
anti-EBMA-LP mouse monoclonal antibody (JF186; a gen-
erous gift from Dr. G. Klein), and anti-LMP-1 mouse
monoclonal antibody (S-12; a generous gift from Dr. E.Kieff) were used as the primary antibodies for immuno-
blotting and/or immunofluorescence.
Reporter gene assay
BOSC23 or COS-7 cells in 24-well culture plates were
transfected with 1 mg of pM-EBNA-2 and 0.16 mg of
FR-luc (Stratagene) together with 0.33 mg of pcDNA4/
HisMaxCvector,pcDNA4/HisMax-EBNA-LP(F)orpcDNA4/
HisMax-EBNA-LPRA(F) as described above. pRL-tk
(0.016 mg; Promega) was also cotransfected, being used
s an internal control for transfection efficiency as de-
cribed by the manufacturer. At 48 h after transfection,
ells were harvested and assayed for luciferase activity
sing the Dual-luciferase reporter assay system accord-
ng to the manufacturer’s instructions (Promega). Fold
ctivation activity was relative to that of the control ex-
ression vector pcDNA4/HisMaxC.
ACKNOWLEDGMENTS
We thank Dr. E. Kieff for the EBNA-LP cDNA and anti-LMP-1 mouse
monoclonal antibody, Dr. G. Klein for the mouse monoclonal antibody to
EBNA-LP, Dr. S. Fujiwara for pSG-E2, Dr. K. Maruyama for pME18S, Dr.
A. D. Miller for the pLNSX vector, Dr. D. Baltimore for the BOSC23 cells,
and Dr. K. Takada for AKATA cells. We are also grateful to Dr. M. Tanaka
and M. Igarashi for making available their materials. We are also
grateful to S. Mitani, M. Mori, and C. Hatanaka for technical assistance.
This study was supported in part by grants for Scientific Research (Y.K.
and K.H.) and a grant for Scientific Research in Priority Areas (K.H.) from
the ministry of Education, Science, Sports and Culture of Japan. Y.K.
was supported by a grant from the Inamori Foundation.
REFERENCES
Alfieri, C., Birkenbach, M., and Kieff, E. (1991). Early events in Epstein-
Barr virus infection of human B lymphocytes. Virology 181(2), 595–
608.
ae, S. C., Yamaguchi-Iwai, Y., Ogawa, E., Maruyama, M., Inuzuka, M.,
Kagoshima, H., Shigesada, K., Satake, M., and Ito, Y. (1993). Isolation
of PEBP2 alpha B cDNA representing the mouse homolog of human
acute myeloid leukemia gene, AML1. Oncogene 8(3), 809–814.
Berenzy, R., and Coffey, D. (1975). Nuclear protein matrix: with newly
synthesized DNA. Science 189, 291–293
Chen, L. F., Ito, K., Murakami, Y., and Ito, Y. (1998). The capacity of
polyomavirus enhancer binding protein 2alphaB (AML1/Cbfa2) to
stimulate polyomavirus DNA replication is related to its affinity for the
nuclear matrix. Mol. Cell. Biol. 18(7), 4165–4176.
ohen, J. I., Wang, F., Mannick, J., and Kieff, E. (1989). Epstein-Barr virus
nuclear protein 2 is a key determinant of lymphocyte transformation.
Proc. Natl. Acad. Sci. USA 86(23), 9558–9562.
ingwall, C., Robbins, J., Dilworth, S. M., Roberts, B., and Richardson,
W. D. (1988). The nucleoplasmin nuclear location sequence is larger
and more complex than that of SV-40 large T antigen. J. Cell Biol.
107(3), 841–849.
ey, E. G., Wan, K. M., and Penman, S. (1984). Epithelial cytoskeletal
framework and Nuclear matrix-intermediate filament scaffold: Three-
dimensional organization and protein composition. J. Cell Biol. 98,
1973–1984.
ammerschmidt, W., and Sugden, B. (1989). Genetic analysis of immor-
talizing functions of Epstein-Barr virus in human B lymphocytes.
Nature 340, 393–397.
arada, S., and Kieff, E. (1997). Epstein-Barr virus nuclear protein LP
stimulates EBNA-2 acidic domain-mediated transcriptional activa-
tion. J. Virol. 71(9), 6611–6618.
KK
K
K
K
K
K
P
P
P
R
R
S
S
S
S
S
S
T
T
Z
Z
Z
413IDENTIFICATION OF NMTS AND NLS OF EBV EBNA-LPJackson, D. A., and Cook, P. R. (1995). The structural basis of nuclear
function. In “Nuclear Matrix: Structural and Functional Organization”
(R. Berezney, and K. W. Jeon, Eds.), pp. 125–150, Academic Press, San
Diego.
Jiang, W. Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., Klein, G., and
Rosen A. (1991). Co-localization of the retinoblastoma protein and the
Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp. Cell Res.
197(2), 314–318.
Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. E. (1984).
Sequence requirements for nuclear location of simian virus 40
large-T antigen. Nature 311, 33–38.
anno, T., Kanno, Y., Chen, L. F., Ogawa, E., Kim, W. Y., and Ito, Y. (1998).
Intrinsic transcriptional activation-inhibition domains of the polyoma-
virus enhancer binding protein 2/core binding factor alpha subunit
revealed in the presence of the beta subunit. Mol. Cell. Biol. 18(5),
2444–2454.
awaguchi, Y., Bruni, R., and Roizman, B. (1997a). Interaction of herpes
simplex virus 1 alpha regulatory protein ICP0 with elongation factor
1delta: ICP0 affects translational machinery. J. Virol. 71(2), 1019–1024.
awaguchi, Y., Nakajima, K., Igarashi, M., Morita, T., Tanaka, M., Suzuki,
M., Yokoyama, A., Matsuda, G., Kato, K., Kanamori, M., and Hirai, K.
(2000). Interaction of Epstein-Barr virus nuclear antigen leader pro-
tein (EBNA-LP) with HS1-associated protein X-1: Implication of cyto-
plasmic function of EBNA-LP. J. Virol. 74(21), 10104–10111.
awaguchi, Y., Van Sant, C., and Roizman, B. (1997b). Herpes simplex
virus type 1 a regulatory protein ICP0 interacts with and stabolizes
the cell cycle regulator cyclin D3. J. Virol. 71(10), 7328–7336.
aye, K. M., Izumi, K. M., and Kieff, E. (1993). Epstein-Barr virus latent
membrane protein 1 is essential for B-lymphocyte growth transfor-
mation. Proc. Natl. Acad. Sci. USA 90(19), 9150–9154.
ieff, E. (1996). Epstein-Barr virus and its replication. In “Virology,” 3rd
ed. (B. N. Fields, D. M. Knipe, P. Howley, R. M. Chanock, M. S. Hirsch,
J. L. Melnick, T. P. Monath, and B. Roizman, Ed.), pp. 2343–2396.
Raven Press, New York.
itay, M. K., and Rowe, D. T. (1996). Protein-protein interactions be-
tween Epstein-Barr virus nuclear antigen-LP and cellular gene prod-
ucts: Binding of 70-kilodalton heat shock proteins. Virology 220(1),
91–99.
Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A., and Kieff, E.
(1991). The Epstein-Barr virus nuclear protein encoded by the leader
of the EBNA RNAs is important in B-lymphocyte transformation.
J. Virol. 65(12), 6826–6837.
Mannick, J. B., Tong, X., Hemnes, A., and Kieff, E. (1995). The Epstein-
Barr virus nuclear antigen leader protein associates with hsp72/
hsc73. J. Virol. 69(12), 8169–8172.
Miller, A. D., Miller, D. G., Garcia J. V., and Lynch C. M. (1993). Use of
retroviral vectors for gene transfer and expression. Methods Enzy-
mol. 217, 581–599.
Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T.,
Yokoyama, K., Soeda, E., and Ohki, M. (1995). Alternative splicing and
genomic structure of the AML1 gene involved in acute myeloid
leukemia. Nucleic Acids Res. 23(14), 2762–2769.
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., Ohki, M. (1991).
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are
clustered within a limited region of a single gene, AML1. Proc. Natl.
Acad. Sci. USA 88(23), 10431–10434.
Mortillaro, M. J., Blencowe, B. J., Wei, X., Nakayasu, H., Du, L., Warren,
S. L., Sharp, P. A., and Berezney, R. (1996). A hyperphosphorylated
form of the large subunit of RNA polymerase II is associated with
splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. USA
93(16), 8253–8257.
Nitsche, F., Bell, A., and Rickinson, A. (1997). Epstein-Barr virus leader
protein enhances EBNA-2-mediated transactivation of latent mem-brane protein 1 expression: A role for the W1W2 repeat domain.
J. Virol. 71(9), 6619–6628.
ear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993). Produc-
tion of high-titer helper-free retroviruses by transient transfection.
Proc. Natl. Acad. Sci. USA 90(18), 8392–8396.
eng, R., Gordadze, A. V., Fuentes Panana, E. M., Wang, F., Zong, J.,
Hayward, G. S., Tan, J., and Ling, P. D. (2000). Sequence, and func-
tional analysis of EBNA-LP, and EBNA2 proteins from nonhuman
primate lymphocryptoviruses. J. Virol. 74(1), 379–389.
etti, L., Sample, C., and Kieff, E. (1990). Subnuclear localization and
phosphorylation of Epstein-Barr virus latent infection nuclear pro-
teins. Virology 176(2), 563–574.
ickinson, A. B., and Kieff, E. (1996). Epstein-Barr virus and its replica-
tion. In “Virology,” 3rd ed., (B. N. Fields, D. M. Knipe, P. Howley, R. M.
Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman,
Eds.), pp. 2397–2446. Raven Press, New York.
obbins, J., Dilworth, S. M., Laskey, R. A., and Dingwall, C. (1991). Two
interdependent basic domains in nucleoplasmin nuclear targeting
sequence: Identification of a class of bipartite nuclear targeting
sequence. Cell 64(3), 615–623.
ilver, P. A., Keegan, L. P., and Ptashine, M. (1984). Amino terminus of
the yeast GAL4 gene product is sufficient for nuclear localization.
Proc. Natl. Acad. Sci. USA 81(19), 5951–5955.
inclair, A. J., Palmero, I., Peters, G., and Farrell, P. J. (1994). EBNA-2 and
EBNA-LP cooperate to cause G0 to G1 transition during immortal-
ization of resting human B lymphocytes by Epstein-Barr virus. EMBO
J. 13(14), 3321–3328.
pector, D. S., Goldman, R. D., and Leinwand, L. A. (1998). The nuclear
matrix: preparation for microscopy and biochemical analysis. Cells:
A laboratory manual 44.1–44.8. Cold Spring Harbor Laboratory Press,
Plainview, NY.
zekely, L., Jiang, W. Q., Pokrovskaja, K., Wiman, K. G., Klein, G., and
Ringertz, N. (1995). Reversible nucleolar translocation of Epstein-Barr
virus-encoded EBNA-5 and hsp70 proteins after exposure to heat
shock or cell density congestion. J. Gen. Virol. 76, 2423–2432.
zekely, L., Pokrovskaja, K., Jiang, W. Q., de The, H., Ringertz, N., and
Klein, G. (1996). The Epstein-Barr virus-encoded nuclear antigen
EBNA-5 accumulates in PML-containing bodies. J. Virol. 70(4), 2562–
2568.
zekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G.
(1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen,
binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci.
USA 90(12), 5455–5459.
akada, K., and Ono, Y. (1989). Synchronous and sequential activation
of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445–449.
omkinson, B., Robertson, E., and Kieff, E. (1993). Epstein-Barr virus
nuclear proteins (EBNA) 3A and 3C are essential for B-lymphocyte
growth transformation. J. Virol. 67(4), 2014–2025.
eng, C., McNeil, S., Pockwinse, S., Nickerson, J., Shopland, L., Law-
rence, J. B., Penman, S., Hiebert, S., Lian, J. B., van Wijnen, A. J., Stein,
J.L, and Stein, G. S. (1998). Intranuclear targeting of AML/CBFalpha
regulatory factors to nuclear matrix-associated transcriptional do-
mains. Proc. Natl. Acad. Sci. USA 95(4), 1585–1589.
eng, C., van Wijnen, A. J., Stein, J. L., Meyers, S., Sun, W., Shopland, L.,
Lawrence, J. B., Penman, S., Lian, J. B., Stein, G. S., and Hiebert, S. W.
(1997). Identification of a nuclear matrix targeting signal in the leu-
kemia and bone-related AML/CBF-alpha transcription factors. Proc.
Natl. Acad. Sci. USA 94(13), 6746–6751.
ou, N., Lin, B. Y., Duan, F., Lee, K. Y., Jin, G., Guan, R., Yao, G., Lefkowitz,
E. J., Broker, T. R., and Chow, L. T. (2000). The hinge of the human
papillomavirus type 11 E2 protein contains major determinants for
nuclear localization, and nuclear matrix association. J Virol. 74(8),
3761–3770.
